Modifying Antiretroviral Therapy in Virologically Suppressed HIV-Infected Patients

  • Author: José R. Arribas, MD (More Info)
  • Section Editor: Eric S. Daar, MD
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 3/17/20 (What's New)


  • There are multiple factors to consider before modifying a suppressive antiretroviral regimen including but not limited to:
    • Genetic barrier of the new regimen in the context of possible archived antiretroviral resistance mutations
    • Duration of virologic suppression prior to considered switch

Action required